Votrient 400mg (Pazopanib Tablet) 400mg

Pazopanib, the active ingredient in Votrient 400mg, works by inhibiting multiple receptor tyrosine kinases. This includes VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-α/β, and c-Kit. By inhibiting these kinases, Pazopanib reduces the blood supply to tumors and slows their growth, leading to anti-angiogenic and anti-tumor effects.

The usual dose of Votrient 400mg is determined by a healthcare professional based on the patient's condition and response to treatment. It is typically taken once daily on an empty stomach, either one hour before or two hours after a meal.

Votrient 400mg should be avoided during pregnancy as it can cause harm to the fetus. It is also advised to avoid breastfeeding while taking this medication due to potential risks to the infant. Always consult a healthcare professional for personalized advice.

To order Votrient 400mg from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. The team will ask you to confirm your trade or institutional credentials and will reply with pricing, availability, shipping, and the necessary import paperwork.

Votrient 400mg is a tyrosine kinase inhibitor specifically used for renal cell carcinoma and soft tissue sarcoma. Compared to other cancer treatments, it offers a targeted approach by inhibiting specific pathways involved in tumor growth and angiogenesis. The choice of treatment depends on the type and stage of cancer, as well as the patient's overall health.

Votrient 400mg should be stored below 25°C, kept in the original pack, and protected from moisture. It is important to follow the storage instructions provided to maintain the medication's effectiveness and safety.

Votrient 400mg is administered orally as a tablet. It should be taken once daily on an empty stomach, either one hour before or two hours after a meal. The tablets should be swallowed whole with a glass of water and not crushed, broken, or chewed.

The most serious risks associated with Votrient 400mg include liver damage, heart problems, bleeding or hemorrhage, perforation or fistula formation, and severe skin reactions. Regular monitoring and close supervision by a healthcare professional are essential to manage these risks.

Votrient 400mg should not be used by individuals with severe liver or heart conditions, those who are pregnant or breastfeeding, and those with a known hypersensitivity to Pazopanib or any of the excipients in the medication. Always consult a healthcare professional for personalized advice.